Racemic Anisodamine Hydrochloride Injection
Function and Efficacy
It has a peripheral anti-M cholinergic receptor effect, can relieve smooth muscle spasms caused by acetylcholine, can also relieve microvascular spasms, and improve microcirculation. It has a relaxing effect on gastrointestinal smooth muscle and inhibits its peristalsis. Its effect is slightly weaker than atropine, and its effect of inhibiting digestive gland secretion is 1/10 of atropine. Its effect of inhibiting salivary gland secretion and dilating pupils is weaker, which is 1/20 to 1/10 of atropine. Because it is not easy to pass through the blood-cerebrospinal fluid barrier, its central effect is also weaker than atropine.
Ingredients
The main ingredient of this product is racemic anisodamine hydrochloride, chemical name: (plusmn;)-6beta;-hydroxy-1alpha;H, 5alpha;H-tropane-3alpha;-ol tropate hydrochloride.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| AnisodamineIngredients |
It has a peripheral anti-M cholinergic receptor effect, can relieve smooth muscle spasms caused by acetylcholine, can also relieve microvascular spasms, and improve microcirculation. It has a relaxing effect on gastrointestinal smooth muscle and inhibits its peristalsis. Its effect is slightly weaker than atropine, and its effect of inhibiting digestive gland secretion is 1/10 of atropine. Its effect of inhibiting salivary gland secretion and dilating pupils is weaker, which is 1/20 to 1/10 of atropine. Because it is not easy to pass through the blood-cerebrospinal fluid barrier, its central effect is also weaker than atropine. More |
17659-49-3 | 6 |
Appearance
This product is a colorless clear liquid.
Indication
Anti-M cholinergic drugs are mainly used to relieve smooth muscle spasms, gastrointestinal colic, biliary spasm, acute microcirculatory disorders and organophosphorus poisoning.
Usage and Dosage
1 Common dosage: 5-10 mg intramuscularly for adults, 0.1-0.2 mg/kg for children, 1-2 times a day. 2 Anti-shock and organophosphorus poisoning: intravenous injection, 10-40 mg for adults, 0.3-2 mg/kg for children, if necessary, repeat the administration every 10-30 minutes, or increase the dose. After the condition improves, the dosing interval should be gradually extended until the drug is stopped.
Adverse Reactions
Common symptoms include dry mouth, flushed face, blurred vision, etc.; rare symptoms include rapid heartbeat, dysuria, etc.; the above symptoms usually disappear within 13 hours. Atropine-like poisoning symptoms may occur when the dosage is too large.
Precautions
It is contraindicated for patients with increased intracranial pressure, acute cerebral hemorrhage, glaucoma, pyloric obstruction, intestinal obstruction and prostatic hypertrophy; it should be used with caution in patients with reflux esophagitis and severe ulcerative colitis.
Special Population Medication
Precautions for children: Use with caution in infants and young children. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Use with caution in the elderly and weak; elderly men often suffer from prostate hypertrophy, which can easily cause prostate congestion and lead to urinary retention after taking the drug.
Drug Interactions
1. When used in combination with amantadine, phenothiazines, tricyclic antidepressants, primidone, procainamide and other anticholinergic drugs, adverse reactions may increase. 2. When used in combination with monoamine oxidase preparations (including furazolidone and procarbazine), the side effects of antimuscarinic effects may be enhanced. 3. It can weaken gastrointestinal motility and delay gastric emptying, affecting some drugs, such as erythromycin staying in the stomach for too long, reducing the efficacy, delaying the absorption of acetaminophen, and increasing the absorption of digoxin, nitrofurantoin and other drugs.
Storage
Keep tightly closed.
Packaging Specification
1ml:10mg
Validity Period
24 months
Manufacturer
Jinling Pharmaceutical Co., Ltd. Nanjing Jinling Pharmaceutical Factory
-
Founded in:
1996-09-16 -
Address:
No. 58, Xingang Avenue, Nanjing Economic and Technological Development Zone -
Tax NO.:
9132019270413930XB -
Registered Funds:
- -
Email: